AI brief of an SEC Form 8-K · EUDA Health Holdings Ltd (EUDA)

EUDA Health issues shares to settle debts, including to CEO, and sells $940,000 in stock

Neutral Impact 3 of 5 financing Written later

EUDA Health Holdings issued 2,317,606 restricted shares on May 16, 2023, to settle debts owed to a major shareholder, its CEO and related companies, and converted a $700,000 note into 700,000 shares. Between May 16 and May 22, 2023, it also sold 940,000 shares at $1.00 each to eight accredited investors for $940,000, which adds to the outstanding share count.

Key points

  • 1,617,606 shares issued May 16, 2023, under five settlement agreements, including 850,306 shares to CEO Kelvin Chen to satisfy a $850,306 claim.
  • 700,000 shares issued May 16, 2023, after James Tan converted a $700,000 note at $1.00 per share.
  • 940,000 shares sold at $1.00 each, for $940,000, to eight accredited investors between May 16 and May 22, 2023.
  • None of the shares are registered under the Securities Act; the company agreed to register resale of the placement shares under registration rights agreements.

The filing

CompanyEUDA Health Holdings Ltd (EUDA)
Form8-K, current report
Filed with the SECMay 26, 2023, 8:40 AM ET
Accession number0001493152-23-019182

Items reported: 1.01 Material Definitive Agreement3.02 Unregistered Equity Sale

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:44 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 26, 2023.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.